secwatch.observer — SEC 8-K summary
======================================

Issuer:     FOXO TECHNOLOGIES INC. (FOXO)
CIK:        0001812360
Form:       8-K
Filed at:   2026-05-28T20:45:42+00:00
Accession:  0001493152-26-025636
Event type: m_and_a
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FOXO licenses epigenetics IP to founder's entity; 3% royalty capped at $1.3M, 40% equity option
--------------------------------------------------------------------------------

- Exclusive worldwide license of two U.S. patents, 13,000+ dataset, and ML models to LongevityFP Technologies, controlled by founder Jon R. Sabes.
- Royalty of 3% of net revenues from commercialization, aggregate cap of $1.3 million.
- Ten-year option for LongevityFP to acquire majority (60% or 100%) of FOXO Labs; if exercised, FOXO gets 40% equity interest.
- Agreement includes mutual releases resolving all prior matters between FOXO and founder Jon Sabes.
- FOXO retains ownership of FOXO Labs and all licensed IP throughout the license period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1812360/000149315226025636/0001493152-26-025636-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1812360/000149315226025636/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-025636

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer